Time points (week) | 0 | 1 | 2 | 3–4 | 5 | 6–9 | 10 | 11–14 | 15 | 16–20 | 21 | 43 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcomes (evaluator rating) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
GRID-Hamilton Rating Scale for Depression | IE | Â | Â | Â | Â | Â | IE | Â | Â | Â | IE | IE |
Structural Interview Guide for Hamilton Anxiety Rating Scale | IE | Â | Â | Â | Â | Â | IE | Â | Â | Â | IE | IE |
Clinical Global Impression | IE | Â | Â | Â | Â | Â | IE | Â | Â | Â | IE | IE |
General Assessment of Functioning | IE | Â | Â | Â | Â | Â | IE | Â | Â | Â | IE | IE |
Structural clinical interview for DSM | IE | Â | Â | Â | Â | Â | Â | Â | Â | Â | IE | IE |
Outcomes (self-report) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Overall Anxiety Severity and Impairment Scale | P | P | P | P | P | P | P | P | P | P | P | P |
Overall Depression Severity and Impairment Scale | P | P | P | P | P | P | P | P | P | P | P | P |
Disorder Specific Measures | P | Â | Â | Â | Â | Â | P | Â | Â | Â | P | P |
EQ-5D | P | Â | Â | Â | Â | Â | P | Â | Â | Â | P | P |
Sheehan Disability Scale | P | Â | Â | Â | Â | Â | P | Â | Â | Â | P | P |
Sense of Authenticity Scale | P | Â | Â | Â | Â | Â | P | Â | Â | Â | P | P |
Treatment mechanism | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Eysenck Personality Questionnaire Revised-Short version, Neuroticism subscale | P | Â | Â | Â | P | Â | P | Â | P | Â | P | P |
Anxiety Sensitivity Inventory-III | P | Â | Â | Â | P | Â | P | Â | P | Â | P | P |
Emotion Regulation Skills Questionnaire | P | Â | Â | Â | P | Â | P | Â | P | Â | P | P |
Emotion Exposure Questionnaire | P | Â | Â | Â | P | Â | P | Â | P | Â | P | P |
Treatment Rationale for Unified Protocol | P | Â | Â | Â | P | Â | P | Â | P | Â | P | P |
Process measures | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Session Rating Scale | Â | P/T | Â | Â | P/T | Â | P/T | Â | P/T | Â | Â | Â |
Credibility/Expectancy Questionnaire | Â | Â | P/T | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Homework Compliance Scale | Â | Â | T | T | T | T | T | T | T | T | Â | Â |
Adverse Event | Â | Â | T | T | T | T | T/IE | T | T | T | IE | IE |
Neurological correlates | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Functional Magnetic Resonance Imaging | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | X |